bullish
CSPC Pharmaceutical Group Buy Target
335 Views30 Sep 2020 16:24
CSPC Pharmaceutical Group (1093 HK) is seeing a rather well behaved pullback cycle that sets up a buy on weakness.
Sell volumes have been light in...
SUMMARY
(Sign Up to Access)Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 2-minute read)
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- CSPC Pharmaceutical Group Buy Target30 Sep 2020
- Initiating Coverage of CSPC (1093 HK) With Narrow Moat Rating, FVE of HKD 21.0 Per Share23 Aug 2018
- CHINA HEALTHCARE - China Improving Healthcare Standards, Positive News for Pharma and Diagnostics30 Jun 2018
- CSPC Pharma Placement: Visible Growth and Good Track Record12 Oct 2017
x